Commonwealth Equity Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.5M Buy
10,577
+832
+9% +$283K ﹤0.01% 1592
2025
Q4
$3.87M Buy
9,745
+338
+4% +$150K 0.01% 1502
2025
Q3
$4.29M Sell
9,407
-519
-5% -$211K 0.01% 1458
2025
Q2
$3.24M Buy
9,926
+1,455
+17% +$403K ﹤0.01% 1643
2025
Q1
$2.29M Buy
8,471
+1,934
+30% +$497K ﹤0.01% 1819
2024
Q4
$1.54M Buy
6,537
+1,234
+23% +$325K ﹤0.01% 2055
2024
Q3
$1.46M Sell
5,303
-449
-8% -$117K ﹤0.01% 2046
2024
Q2
$1.4M Buy
5,752
+158
+3% +$24.9K ﹤0.01% 2034
2024
Q1
$836K Buy
5,594
+1,365
+32% +$228K ﹤0.01% 2377
2023
Q4
$809K Sell
4,229
-143
-3% -$24.4K ﹤0.01% 2319
2023
Q3
$774K Buy
4,372
+363
+9% +$69.3K ﹤0.01% 2250
2023
Q2
$761K Buy
4,009
+348
+10% +$69K ﹤0.01% 2298
2023
Q1
$733 Sell
3,661
-1,546
-30% -$325K ﹤0.01% 2258
2022
Q4
$1.24M Buy
5,207
+433
+9% +$92.4K ﹤0.01% 1820
2022
Q3
$955K Buy
4,774
+198
+4% +$37.8K ﹤0.01% 1929
2022
Q2
$667K Sell
4,576
-442
-9% -$62.7K ﹤0.01% 2206
2022
Q1
$819K Sell
5,018
-193
-4% -$29.4K ﹤0.01% 2140
2021
Q4
$883K Buy
5,211
+942
+22% +$175K ﹤0.01% 2084
2021
Q3
$806K Sell
4,269
-103
-2% -$19.3K ﹤0.01% 2091
2021
Q2
$741K Sell
4,372
-444
-9% -$65K ﹤0.01% 2153
2021
Q1
$679K Buy
4,816
+476
+11% +$71.6K ﹤0.01% 2080
2020
Q4
$564K Sell
4,340
-7
-0.2% -$935 ﹤0.01% 2070
2020
Q3
$632K Buy
4,347
+133
+3% +$18.9K ﹤0.01% 1808
2020
Q2
$624K Buy
4,214
+84
+2% +$11.3K ﹤0.01% 1731
2020
Q1
$449K Sell
4,130
-1,470
-26% -$170K ﹤0.01% 1764
2019
Q4
$644K Sell
5,600
-1,459
-21% -$145K ﹤0.01% 1715
2019
Q3
$567K Sell
7,059
-37
-0.5% -$2.93K ﹤0.01% 1736
2019
Q2
$514K Buy
7,096
+76
+1% +$5.83K ﹤0.01% 1775
2019
Q1
$656K Sell
7,020
-2,051
-23% -$172K ﹤0.01% 1567
2018
Q4
$661K Buy
9,071
+5,802
+177% +$446K ﹤0.01% 1459
2018
Q3
$286K Buy
3,269
+206
+7% +$20.7K ﹤0.01% 2209
2018
Q2
$302K Buy
3,063
+100
+3% +$9.92K ﹤0.01% 2116
2018
Q1
$352K Sell
2,963
-2,910
-50% -$375K ﹤0.01% 1945
2017
Q4
$746K Sell
5,873
-1,159
-16% -$146K ﹤0.01% 1406
2017
Q3
$826K Sell
7,032
-267
-4% -$22.8K ﹤0.01% 1294
2017
Q2
$582K Buy
7,299
+895
+14% +$57.2K ﹤0.01% 1468
2017
Q1
$328K Sell
6,404
-180
-3% -$8.32K ﹤0.01% 1788
2016
Q4
$247K Buy
6,584
+780
+13% +$32.7K ﹤0.01% 1916
2016
Q3
$393K Buy
5,804
+100
+2% +$7.05K ﹤0.01% 1528
2016
Q2
$317K Buy
+5,704
New +$359K ﹤0.01% 1623

Other funds holding ALNY